Roche ENSPRYNG Shows MOGAD Clinical Benefit Data
BASEL, Switzerland, April 2026 Roche reported new clinical findings demonstrating the effectiveness of ENSPRYNG® (satralizumab) in reducing relapse risk...
clinical data
Advertisement
Monopar Reports Phase 3 ALXN1840 Data at AAN 2026
WILMETTE, Ill., April 19, 2026 Monopar Therapeutics announced new Phase 3 clinical data demonstrating greater neurologic benefit of ALXN1840...
Neurelis Shows Strong Seizure Control Data for VALTOCO at AAN
SAN DIEGO, Calif., April 16, 2026 Neurelis, Inc. has announced new clinical and real-world analyses demonstrating the effectiveness of...
PDS Biotech Reports Breakthrough Phase 2 mCRC Results
Princeton, New Jersey, U.S. | April 15, 2026 PDS Biotechnology has announced the publication of positive interim Phase 2...
NeoGenomics Advances AI-Driven Oncology Insights at AACR
Fort Myers, Florida | April 13, 2026 NeoGenomics, Inc. has announced the presentation of multiple scientific abstracts at the...
Advertisements
Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers
Tel Aviv, Israel & Tokyo, Japan | April 9, 2026 Imagene AI has announced a strategic collaboration with Daiichi...
Johnson & Johnson Showcases TECNIS PureSee IOL Data
Jacksonville, Florida | April 10, 2026 Johnson & Johnson has presented new clinical data for its TECNIS PureSee™ intraocular...
KalVista Showcases EKTERLY Data at AAAAI 2026 Meet
FRAMINGHAM, Mass. & SALISBURY, England, Feb. 12, 2026 — KalVista Pharmaceuticals announced the presentation of new clinical and real-world...
Autonomix Reports Rapid, Durable Pain Relief in Pancreatic Cancer
THE WOODLANDS, Texas | January 9, 2026 — Autonomix Medical, Inc. has reported compelling proof-of-concept (PoC) clinical data demonstrating...
Paxalisib Boosts Anti-Tumor Immunity in Advanced Breast Cancer
SYDNEY, Dec. 10, 2025 — Kazia Therapeutics Limited (NASDAQ: KZIA) unveiled compelling clinical and translational data highlighting the ability...
Advertisement
